Recently, an incident in Wuhan, Hubei Province, has aroused widespread concern in society.
A citizen bought a cold medicine worth 220 yuan on the strong recommendation of a salesman at a pharmacy due to a cold, and there were only two tablets in this expensive cold medicine!
The two lone pills in the pill box were worth as much as 110 yuan each. This is undoubtedly too much luxury for an ordinary salaried class.
Not only that, but in the process of carefully inspecting the pill box, the citizen also found an unusually large instruction manual.
Not only is this instruction manual larger than a standard newspaper, but its heavy paper is densely packed with text.
This unexpected discovery made the citizen and his family cry and laugh, and even couldn't help but quip: "I didn't expect that this time I bought the medicine and came with a newspaper, it seems that this instruction manual must be worth 100 yuan!."”
After this ** was uploaded to the Internet, it immediately sparked heated discussions among netizens. Some netizens humorously joked: "After reading this manual, my cold is cured!."”
Some people also questioned, "Is it possible that the larger the instructions, the more toxic they be?"More professional doctors came forward to explain that this cold medicine is actually a special medicine, although it is expensive, but its effect is really not to be underestimated.
This led to a series of discussions on the issue of drugs. In fact, it is not difficult to find that in recent years, the number of drugs on the market** has generally shown an upward trend. The reason for this involves many complex factors:
Of course, the cost of drug development cannot be ignored. From clinical trials to safety evaluations to validation of efficacy, each requires a huge investment in funding.
Ultimately, these costs will be reflected in the sale of medicines**. Especially for rare disease drugs, due to their high research and development costs and limited target consumer groups, drugs are often more expensive.
Patent protection and competition in the market for generic drugs have also had an impact on medicines**. During the patent protection period, the original drug company has the exclusive right to operate the market, which gives the company the opportunity to optimize the R&D cost through a higher selling price.
However, once the patent expires, other companies can produce generic drugs, which will intensify market competition and promote the downward adjustment of drug **.
In addition, the drug is also affected by the relationship between market demand and **. For those drugs or special drugs that are in short supply, due to the strong market demand, there is often a situation where supply exceeds demand, which also makes the drug ** high.
This incident is not simply a problem of a box of drugs, but touches on the deep-seated problems of drug pricing, efficacy, research and development, and many other aspects.
From another point of view, if this cold medicine worth 200 yuan can significantly ** cold symptoms in a short period of time, then its high ** may be able to gain a certain degree of understanding and recognition.
In this case, the high efficiency and rapid effect of the drug can become the rationality basis for its first position to a certain extent.
The reason why this matter has been pushed to a climax is because it has become everyone's consensus that drugs are generally expensive. Normally, when the supply is sufficient, the ** will decline.
Nowadays, there are a large number of pharmacies on the street, but the ** is still high, which is obviously not in line with the law of economic development, so what is the deep logic behind it?